Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Deposits, lending jumps at Secure Trust Bank

(Sharecast News) - Secure Bank Trust said on Thursday it had moved closer to its £4bn net lending target, despite heightened turbulence across global markets, following a strong first quarter. The challenger bank said deposits in the three months to 31 March rose 15.4% year-on-year, to £3.37bn, while the net loan book increased 10.5% at £3.73bn.

Within lending, business and consumer balances rose by 4.9% and 1.8% respectively.

Quarter-on-quarter, deposits grew by 3.9% and net lending by 3.2%.

David McCreadie, chief executive, said: "The group delivered strong net lending growth in the period, moving closer towards our £4bn net lending ambition.

"We continue to manage the trajectory towards this level prudently. We are monitoring for potential impacts of the current turbulence in global markets and across the geopolitical landscape."

Secure Trust also confirmed it had sold £25.8m of defaulted vehicle finance loan balances after the period end.

The balances built up in 2024, after collections were paused while the Financial Conduct Authority carried out a Borrowers in Financial Difficulty review.

"This transaction is the first of several initiatives that will allow operational resources to be deployed more effectively to manage early-stage arrears and defaults," it noted.

As at 1100 BST, shares in Secure Trust were up 3% at 625.6p.

Shore Capital, which acts as joint broker to the bank, said: "Secure Trust has published an encouraging first quarter trading up, which demonstrates continued progress towards management's £4bn net loan book target.

"The group also continues to deliver cost savings in line with its plan."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.